Given that DNA repair proteins can lessen the activity of cytarabine and several of these factors are HSP90 client proteins [25], we assessed whether ganetespib could enhance the activity of cytarabine in AML blasts and AML cell lines. Here, XRCC6P5 is linked to acute myeloid leukemia.